MRNA
Moderna Inc
182.60$
+5.6%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -955.8% | – | 61.6% | -161.1% | -270.1% | -955.5% | 738.4% | 76.8% | 26.4% | -45.5% | -93.9% | -96.3% | |
| 9.8% | – | 13.9% | 10.0% | 20.3% | 64.6% | 11.4% | 1.3% | 1.8% | 9.1% | 5.9% | 11.1% | |
| – | – | 36.3% | 19.5% | 59.2% | 168.9% | 33.9% | 0.8% | 1.2% | 4.5% | 13.4% | 24.8% | |
| 646.8% | – | 38.6% | 20.0% | 60.0% | 169.5% | 56.7% | -1.0% | -1.6% | – | – | – | |
| – | – | 208.5% | -66.7% | -34.8% | -111.7% | 938.9% | 5.6% | -18.3% | -2.0% | -2.4% | 13.1% | |
| 0.0% | – | 30.6% | 28.4% | 86.3% | 65.7% | 24.6% | 1.6% | 2.1% | 10.3% | 32.9% | 9.9% | |
| 1.2% | – | -598.4% | 202.2% | -304.0% | -31.1% | -609.1% | -48.1% | -27.4% | 61.4% | 60.9% | 100.1% | |
| – | – | 0.6% | 0.7% | – | – | 2.6% | 0.7% | 1.0% | 3.9% | – | – | |
| 1,190.4% | – | 0.0% | 0.0% | -6.7% | 6.0% | 2.6% | -4.8% | -17.6% | -16.8% | 0.0% | – | |
| -50.0% | – | 1.3% | 0.7% | 7.7% | 2.0% | -2.3% | -0.8% | -1.0% | -3.9% | -0.3% | 28.8% | |
| 1,138.8% | – | 436.3% | 0.1% | 1,001.4% | 106.4% | 740.7% | -4.9% | -18.3% | -20.1% | 1.8% | 30.5% | |
| 183.0% | – | -100.5% | 41.2% | 427.3% | -880.2% | 870.1% | 23.8% | -19.3% | -4.2% | -31.2% | 34.4% | |
| – | – | 31.0% | -189.4% | -356.4% | -1,021.2% | 713.9% | 75.2% | 24.3% | -55.9% | -126.8% | -106.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.